Sign Up For Our
FREE Newsletter


Timely Market Commentary
Daily Stock Picks
News Analysis

Email Address: * Required

Country:
Zipcode:

 
 

Posts Tagged ‘weight-loss’

MSLP, NTRI, NUTR - DoubleInStocks.com - News - Nutrition for A Healthy Lifestyle

Tuesday, August 17th, 2010

money 1
signup3m

__

mslp_logo_171x112

MusclePharm Corporation (OTCBB:MSLP) , one of the fastest growing nutritional supplement companies in the United States has reported the shipment of $1.4 million of multiple MusclePharm products from its new manufacturing partnership in the past six weeks.

MusclePharm’s multiple products have expanded into 1,200 of the top GNC stores in the United States, as well as over 450 Vitamin Shoppe stores. MusclePharm’s award-winning products — Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon and Shred Matrix—are also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.

“The MusclePharm brand, which is closely aligned with the rapidly growing UFC, and the sport of MMA, is expanding into many health and wellness channels beyond these core markets,” commented MusclePharm’s Chief Executive Officer Mr. Brad Pyatt. “Our unique nutritional formulations backed by a highly targeted branding campaign are making MusclePharm products a part of many fitness enthusiasts, including world class athletes as well as anyone who wants to live a healthy lifestyle.”

The Company expects its new manufacturing partnership, which is CGMP and NSF certified, will ensure superior product quality and will improve shipping efficiencies in the coming quarters. All product development materials are qualified in their in-house laboratory equipped with the latest in analytical technology including High Pressure Liquid Chromatography (HPLC), Gas Chromatography (GC), and Fourier Transform Near Infrared (FT-NIR). They also have Atomic Absorption for Heavy Metals analysis and Solaris for accelerated microbial testing.

“We are very excited to upgrade our manufacturing partner. They have the capacity to meet our growing demand and are committed to effectively managing all the rigorous quality systems that drive our business, from raw materials and manufacturing to packaging and distribution to ensure MusclePharm finished products are safe, effective and FDA compliant for customer use,” added Mr. Brad Pyatt.

MusclePharm is a major sponsor of UFC superstars Anderson Silva and Rashad Evans, whose exciting fighting styles and popularity have given MusclePharm added exposure as it expands on a worldwide level. MusclePharm has also sponsored more than 50 UFC and World Extreme Cagefighting (WEC) fighters, and is a title sponsor for the WEC, a sister company to the UFC that attracts more than one million viewers for its regular broadcasts on Versus.

http://doubleinstocks.com/img/mslp_bottles_227x180.gif

__

NutriSystem Inc. (NASDAQ: NTRI)

Cost of Weight Loss in America: Many Americans Would Forgo a Job Promotion to Lose 10 Pounds, Reports Nutrisystem Diet Index

In spite of facing the deepest recession since the Great Depression and record unemployment rates, many Americans would pass up a work promotion to drop 10 to 20 pounds, according to the new Nutrisystem Diet Index™ issued today by Nutrisystem, Inc.®, a leading provider of weight management programs and services.

Americans would also rather give up sex than gain weight, and they’d toss their cell phones and give up watching TV to have a toned tummy, according to the new findings.

The Nutrisystem Diet Index™ is a new series of national consumer surveys tracking America’s diet behaviors, attitudes and trends throughout the year. Each survey has a scale that measures America’s current diet and lifestyle behavior and choices.

“The fact of the matter is, America is obsessed with dieting and weight loss, but the majority of Americans aren’t eating healthier or getting thinner,” said Joe Redling, chairman and CEO of Nutrisystem, Inc. “We’ve developed the Nutrisystem Diet Index™ to better understand America’s attitudes toward dieting and to start a dialogue about healthy dieting and healthy lifestyle habits and trends.”

The first Nutrisystem Diet Index™ revealed that Americans place a high value on being healthy, but they abandon the idea of achieving a healthier weight and lifestyle, because they ultimately feel their goals are too difficult to attain and maintain.

The American lifestyle is also a factor. Inconveniences of work, giving up favorite foods, not having the time to plan ahead, cooking for a larger family and the cost of healthy foods are cited as some of the biggest barriers.

KEY NUTRISYSTEM DIET INDEXFINDINGS

The Nutrisystem Diet Index revealed that Americans are clearly showing signs of struggle. According to the Index, Americans are at the midway mark on healthy diet and lifestyle choices, scoring a 5.1 on a ten point scale – with one being an “unhealthy diet and lifestyle” and ten being a “healthy diet and lifestyle” – when asked basic questions about their eating habits, diet behaviors and lifestyle choices.

The Nutrisystem Diet Index showed:

  • Only 35 percent of Americans fall into the “healthy lifestyle” category on the Index, by making healthy food and portion choices and by exercising regularly.
  • 30 percent of Americans fall into the “unhealthy lifestyle” category and have dieted an average of 20 times in their life, using five different diet plans
  • 35 percent of Americans have dieted an average of six times in their life, using two different diet plans
  • Nearly 1/3 of Americans (29 percent) have tried dieting over the past eleven months, and more than half of Americans (51 percent) have dieted within the past two years

Additionally, nearly a third of Americans confess to being self-conscious about their bodies and the Nutrisystem Diet Index reveals insight into Americans’ attitudes about their health, appearance and lifestyle during the height of swimsuit season.

Additional findings from the survey include:

  • A majority of Americans (66 percent) who say they need to lose weight to feel sexier than they currently do, think it will take an average of 23 pounds of weight loss for this to happen
  • More than half (52 percent) of American women would take a summer without sex over gaining 10 pounds; a quarter of American men (25 percent) said they would make the same sacrifice
  • More Americans would prefer to shed 10 to 20 pounds this summer (25 percent) than get promoted at work (20 percent)
  • Almost three out of four Americans (73 percent) are willing to give up television, their cell phones or their computers for a flat tummy this beach season
  • Nearly half (46 percent) of the country chose not to diet, even when they knew they needed to lose weight, because they didn’t want to give up their favorite foods
  • Almost all dieters (93 percent) find at least one aspect of their dieting plan to be challenging; the majority said they aren’t able to control cravings (71 percent) and find portion size an obstacle to their success (64 percent)

http://www.nutrisystem.com

__

nutr_logo_200x72

Nutraceutical International Corp. (NASDAQ:NUTR) is an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores.

Internationally, Nutraceutical International Corp. markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers.

The company’s core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements.

Nutraceutical believes that the consolidation and integration of these acquired businesses provides ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.

Nutraceutical International Corp. manufactures and sells nutritional supplements and other natural products under numerous brands including Solaray, KAL, Nature’s Life, LifeTime, Natural Balance, bioAllers, Herbs for Kids, NaturalCare, Health from the Sun, Life-flo, Organix South, Pioneer®and Monarch Nutraceuticals.

In addition, Nutraceutical International Corp. owns neighborhood natural food markets, which operate under the trade names The Real Food Company, Thom’s Natural Foods and Cornucopia Community Market. This company also owns health food stores, which operate under the trade names Fresh Vitamins and Granola’s.

http://www.nutraceutical.com

__

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).

____________________

Sign Up for our FREE Daily Stock Newsletter

____________________

http://doubleinstocks.com/img/doubleinstocks_buscard.jpg

ctse16

DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

***

 
Share/Bookmark
 

New Study Suggests Online Diet Programs Are Very Effective for Weight-Loss Maintenance

Friday, July 30th, 2010

crwe-newswire

commentary pen

 

 

FORT LAUDERDALE, FL–(CRWENewswire - 07/30/10) - eDiets.com, Inc. (NASDAQ:DIET) — A new study published in the Journal of Medical Internet Research confirms what eDiets has known since it pioneered the online dieting industry in 1998: An online weight-loss program can help individuals maintain their results and avoid weight gain.

The study by Kaiser Permanente Center for Health Research found that regular users of a weight-loss site developed specifically for the study maintained more of their original weight loss than those who logged in less frequently. Participants recorded their weight, workout times and used the site’s interactive bulletin board to interact with one another.

The positive results validate what eDiets has seen time and again: online tracking, accountability, community and professional support are all key to healthy weight maintenance.

As a leading provider of weight-loss services, eDiets offers the best mix of online and personal support all in one place to help our members achieve their weight-loss goals. Members gain access to hundreds of delicious, portion-controlled recipes that can be switched in and out of their specific plan at the click of a button.

Included are an assortment of tools and features to help members track their progress and stay motivated. Each week, members are encouraged to check in with their current weight and measurements, which are used to automatically calculate meal plans designed to help members stay on track to their goal.

“I joined eDiets for the online support. I was skeptical of the support boards at first, but the Experts and other members online were key sources of accountability. I had people to shoot it to me straight when I needed it, no enablers. I also loved the online meetings; those are great tools to keep me focused and to fill in gaps on things I didn’t know. Without the knowledge I gained from eDiets, I would not have found the power to change my life,” says eDiets Member Tara, who lost 94lbs since joining eDiets.com.

Members can journal, provide feedback and ask questions of our registered dietitians and support staff, online or by phone.

“We allow you to continue your program the way you want to and at your convenience. In this day and age, convenience and accessibility are important,” says eDiets Director of Nutrition Services Pamela Ofstein. “eDiets provides all the tools you need and gives you the education and guidance to help you reach your goals — any time of day.”

Find out more about how eDiets can work for you by visiting www.eDiets.com. For press-related questions or interviews, please contact our PR Desk line at 954-703-6156. For more details about the study, click here.

About eDiets:
eDiets.com, Inc. is a leading provider of personalized nutrition, fitness and weight-loss programs. eDiets features its award-winning, fresh-prepared diet meal delivery service as one of the more than 20 popular diet plans on its flagship site, www.eDiets.com. Tara, featured above, lost 94lbs in 55 months on the Glycemic Impact Plan and has received promotional discounts as a member of our testimonial program. Active eDiets members can generally expect to lose about two pounds per week during the first five weeks of the program. The company also provides a broad range of customized wellness and weight management solutions for Fortune 500 clients. For more information, visit www.eDiets.com.

 

 

Disclaimer:
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of Crown Equity Holdings or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company mentioned or referred to in the article.

 
Share/Bookmark
 

Orofino Gold and VIVUS Investor Stock Watch

Wednesday, July 14th, 2010

<<

money 1
signup3m

__

Orofino Gold Corp.

ORFG, Orofino Gold Corp. (Other OTC: ORFG.PK)

MORE BANG FOR YOUR BUCK - GOLD, SILVER AND COPPER

ORFG Last Traded Price: $0.13

Three of the hottest metals in terms of price and demand are gold, silver and copper. Current reports indicate that this trend is likely to continue.

Although copper demand had fallen off due to the economic slump worldwide, demand is starting to rise.

Rather than buying these metals as commodities, savvy investors can invest in a company that intends to mine all three of these metals in Columbia.

Orofino Gold Corp. has plans to mine gold along with silver and copper at properties it has acquired in Columbia, the new hot spot for gold mining. Orofino Gold believes that the area it will be mining will result in more than a million ounces of gold and large amounts of silver and copper as well.

Orofino will now implement an airborne magnetometer program, as well as begin site preparation for the diamond drilling planned to take place in the second quarter of 2010.

Gold has a lot of uses besides as a currency, or medium of exchange, Gold is used for rings, watches, and necklaces, its main use is mostly jewelry, but gold leaf is used in some foods, gold also is used in a lot of high end electronics because it is a good conductor.

Gold is useful in making ornaments, decorative linings and in electrical contacts for better conductivity. Gold could also be used with TV’s, phones, and many other items. If the company is right, this could be a homerun for investors.

Check out ORFG’s recent YTD chart below.

http://doubleinstocks.com/img/orfg_6mo.jpg

About ORFG

OROFINO GOLD CORP. is a new high growth gold company whose mandate is to acquire, explore and develop to compliant proven reserves major gold targets in historically rich gold bearing jurisdictions of Mexico and Colombia two of the most significant gold producing countries in the world. To this end OROFINO has signed an option agreement to acquire several properties in Colombia.

OROFINO’s competitive advantages are the close long term relationships to Mexico and Colombia with their numerous high quality low cost gold opportunities. OROFINO has a Spanish speaking team with geological leadership with over 30 years in Mexico and 28 years in Colombia. The company has performed due diligence on many prospective properties and has categorized three as good to high priority, high return opportunities for immediate investment. These properties are in areas of known gold reserves, low production costs and multi million ounce potential.
The company plans to drill it’s first gold prospect in the first quarter of 2010.

Orofino Gold’s Website

__

http://doubleinstocks.com/img/vvus_vivus.jpg

VVUS, VIVUS Inc. (Nasdaq: VVUS)

Data on VIVUS’ Qnexa to be Presented at International Congress on Obesity

VVUS Last Traded Price: $12.71

VIVUS on July 12th announced that data on Qnexa®, an investigational drug candidate, will be presented at the 11th International Congress on Obesity (ICO) in Stockholm, Sweden.

Kishore Gadde, MD, director of obesity clinical trials at Duke University, will make an oral presentation, “Low-Dose, Controlled-Release Phentermine/Topiramate for Reduction of Weight, Related Risks in Overweight/Obese Adults With 2 Comorbidities,” on Monday, July 12 at 2:45 PM CET.

The 2nd presentation is on Wednesday, July 14, at 1:00 PM CET. David Allison, MD, professor and director of the Nutrition Obesity Research Center at the University of Alabama at Birmingham, will make a poster presentation, “Weight Loss at 56 Weeks in Obese Adults With Low-Dose, Controlled-Release Phentermine/Topiramate,”.

  • Worldwide, there are more than 1 billion overweight adults—at least 300 million are clinically obeVVse.Obesity is associated with excess mortality due to comorbidities (eg, cardiovascular disease, diabetes, hypertension).
  • Modest weight loss (5%-10%) can result in a marked reduction in the risk of obesity-related metabolic and cardiovascular events.
  • Standard treatments for obesity (diet and exercise) achieve marginal weight loss.
  • Currently approved weight-loss agents are often poorly tolerated and fail to achieve clinically meaningful long-term efficacy.

The FDA will convene an outside panel of experts Thursday to review Vivus’ approval application for the weight-loss drug Qnexa. Vivus is trying to become the first company in more than a decade to gain U.S. approval for a new weight-loss drug. Two other companies — Arena Pharmaceuticals(ARNA) and Orexigen Therapeutics(OREX) — are fast on its heels.

Qnexa’s safety and not the drug’s ability to help patients lose weight, was the major concern entering Thursday’s meeting. In its briefing document Tuesday, FDA’s safety review highlights five areas of “particular interest” related to Qnexa — pregnancy risk, psychiatric-related adverse events, cognitive-related adverse events, metabolic acidosis and cardiovascular events.

In the FDA’s review of Qnexa, posted online Tuesday as part of the briefing documents for Thursday’s advisory panel, pooled data from two large phase III studies demonstrated that patients treated with low, medium and high doses Qnexa lost between 3 percent, 7 percent and 9 percent of their body weight, respectively, adjusted for the weight-loss reported for patients treated with a placebo.

About VIVUS

VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. The company’s lead product in clinical development, Qnexa®, has completed phase 3 clinical trials for the treatment of obesity and an NDA has been filed and accepted by the FDA, with an action date of October 28, 2010. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a potentially best-in-class PDE5 inhibitor for the treatment of erectile dysfunction. MUSE® (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS.

VIVUS Website

__

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

 

Disclaimer

: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.DoubleInStocks publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.

signup3m


 

ctse16

DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

 

** The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.

 
Share/Bookmark